These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Review of second-line chemotherapy for advanced gastric adenocarcinoma. Wilson D; Hiller L; Geh JI Clin Oncol (R Coll Radiol); 2005 Apr; 17(2):81-90. PubMed ID: 15830569 [TBL] [Abstract][Full Text] [Related]
8. Challenges in first line chemotherapy and targeted therapy in advanced gastric cancer. Garrido M; Fonseca PJ; Vieitez JM; Frunza M; Lacave AJ Expert Rev Anticancer Ther; 2014 Aug; 14(8):887-900. PubMed ID: 24953238 [TBL] [Abstract][Full Text] [Related]
9. Phase II clinical trials on investigational drugs for the treatment of pancreatic cancers. Kim EJ; Semrad TJ; Bold RJ Expert Opin Investig Drugs; 2015 Jun; 24(6):781-94. PubMed ID: 25809274 [TBL] [Abstract][Full Text] [Related]
11. The role of oral fluoropyrimidines in the treatment of advanced gastric cancer. Pieters A; Laurent S; Dero I; Van Damme N; Peeters M Acta Gastroenterol Belg; 2008; 71(4):361-6. PubMed ID: 19317275 [TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy for advanced gastric cancer--our possibilities in 2007]. Dank M; Torgyík L; Szentmártoni G Magy Onkol; 2007; 51(3):209-17. PubMed ID: 17922060 [TBL] [Abstract][Full Text] [Related]
13. Is there a role for second-line chemotherapy in advanced gastric cancer? Wesolowski R; Lee C; Kim R Lancet Oncol; 2009 Sep; 10(9):903-12. PubMed ID: 19717092 [TBL] [Abstract][Full Text] [Related]
14. Palliative chemotherapy for gastroesophageal cancer in old and very old patients: A retrospective cohort study at the National Center for Tumor Diseases, Heidelberg. Berger AK; Zschaebitz S; Komander C; Jäger D; Haag GM World J Gastroenterol; 2015 Apr; 21(16):4911-8. PubMed ID: 25945004 [TBL] [Abstract][Full Text] [Related]
15. An update on biochemotherapy of advanced gastric and gastroesophageal adenocarcinoma. Haghighat P; Bekaii-Saab T J Natl Compr Canc Netw; 2008 Oct; 6(9):895-900. PubMed ID: 18926099 [TBL] [Abstract][Full Text] [Related]
16. How does a drug get to phase III trials? Reynolds T J Natl Cancer Inst; 2000 Oct; 92(19):1555. PubMed ID: 11018084 [No Abstract] [Full Text] [Related]
17. Treatment outcome of anti-angiogenesis through VEGF-pathway in the management of gastric cancer: a systematic review of phase II and III clinical trials. Mawalla B; Yuan X; Luo X; Chalya PL BMC Res Notes; 2018 Jan; 11(1):21. PubMed ID: 29329598 [TBL] [Abstract][Full Text] [Related]
18. The treatment of advanced gastric cancer: new findings on the activity of the taxanes. Van Cutsem E Oncologist; 2004; 9 Suppl 2():9-15. PubMed ID: 15161986 [TBL] [Abstract][Full Text] [Related]
19. New chemotherapy strategies for gastric cancer. Kubota T In Vivo; 2008; 22(3):273-8. PubMed ID: 18610735 [TBL] [Abstract][Full Text] [Related]
20. Capecitabine for the treatment of gastric cancer. Kim TY; Oh DY; Bang YJ Expert Rev Gastroenterol Hepatol; 2015; 9(12):1471-81. PubMed ID: 26470733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]